Sentence examples for mutation for all from inspiring English sources

Surprisingly, when both mutations are present in the same gene, the pol2-Y831A mutation strongly suppresses the mutator effects of the pol2-4 mutation for all three markers tested in both MMR-proficient and MMR-deficient strains.

There was no difference in the OPA score according to the presence of the D816V KIT mutation for all patients whose classification was known or for patients whose mastocytosis was confirmed by a central review of pathological and clinical data.

For molecular diagnosis, we first screened the recurrent founder mutation for all XP-C suspected patients.

Table 2 details all the relevant clinical information as well as the genetic mutation for all affected index patients.

Finally, restoring synaptic vesicle trafficking within the octopaminergic neurons of animals carrying a null mutation for all aminergic signaling [ 13] is sufficient to restore odor-tracking behavior.

In the present paper, we have used the term "compensatory mutation" for all mutations that are not on the main neutral network, irrespective of their distance to this network.

We estimated the cancer risk for first-degree relatives of mutation carriers for all mutations and for each mutation separately, using Kaplan Meier survival analysis.

High precision was demonstrated for the 3 mutant sample levels and WT, with at least 99% correct mutation calls for all mutation assays across multiple lots, platforms and operators for both within- and between-run experiments.

We compiled the mutation spectra for all mutations that significantly affected the strengths of donor and acceptor splice sites and compared these with the average information contents at each position.

The acquisition of resistance mutations for all ARV classes was identical to those found in global analyses, indicating that NRTI- and PI-associated mutations accumulated faster for subtype B from year 4 of exposure, while NNRTI mutations did not differ between both groups.

We have narrowed these intervals as far as possible using all available molecularly defined deficiencies, and in each case have tested putative loss of function mutations for all the genes for which stocks are available, but have not found any additional potential Rho1-interacting genes (Table S2).